Empresa Oncolytics Biotech Inc. Nasdaq
Acciones
CA6823101077
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01/04/03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/20 |
Jon Patton
IRC | Investor Relations Contact | - | 01/08/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07/09/22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09/01 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08/06/15 |
James Parsons
BRD | Director/Board Member | 58 | 16/06/22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18/06/14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11/05/11 |
Wayne Pisano
CHM | Chairman | 69 | 09/05/13 |
Deborah Brown
BRD | Director/Board Member | - | 02/11/17 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Información de la empresa
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
+29,77 % | 49,18 mil M | |
+1,00 % | 42,11 mil M | |
+50,47 % | 40,37 mil M | |
-5,26 % | 28,85 mil M | |
+13,68 % | 26,09 mil M | |
-22,99 % | 18,71 mil M | |
+8,22 % | 13,26 mil M | |
+32,41 % | 12,32 mil M | |
-1,62 % | 11,99 mil M |